2-Methyl-N-(4-methylpyridin-2-yl)-5-oxo-4-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide

Catalog No. :
ACHIDR110
CAS No. :
361193-46-6
Molecular Formula :
C23H23N3O2
Molecular Weight :
373.46

IUPAC Name:2-methyl-N-(4-methylpyridin-2-yl)-5-oxo-4-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide

2-Methyl-N-(4-methylpyridin-2-yl)-5-oxo-4-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-N-(4-methylpyridin-2-yl)-5-oxo-4-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide
IUPAC Name2-methyl-N-(4-methylpyridin-2-yl)-5-oxo-4-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide
MDL No.MFCD03933847
Molecular FormulaC23H23N3O2
Molecular Weight373.46
SMILESO=C(C1=C(C)NC2=C(C(CCC2)=O)C1C3=CC=CC=C3)NC4=NC=CC(C)=C4
InChI KeyCJTSOEGNQYXLKQ-UHFFFAOYSA-N
SynonymSALOR-INT L218790-1EA;2-ME-N(4-ME-2-PYRIDINYL)-5-OXO-4-PH-1,4,5,6,7,8-HEXAHYDRO-3-QUINOLINECARBOXAMIDE
CAS No.361193-46-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHIDR110 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHIDR110 route product structure diagram
    ACHIDR110361193-46-6
Inquiry

2. ACHIDR110 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHIDR110 route product structure diagram
    ACHIDR110361193-46-6
Inquiry

Comments (0)